Sunshine Biopharma Inc (NASDAQ:SBFM) does about 667.85K shares in volume on a normal day but saw 162615 shares change hands in the recent trading day. The company now has a market cap of 7.00M USD. Its current market price is $3.24, marking an increase of 8.00% compared to the previous close of $3.00. The 52 week high reached by this stock is $608.00 whilst the lowest price level in 52 weeks is $2.11.
Sunshine Biopharma Inc (SBFM) has a 20-day trading average at $2.92 and the current price is -99.47% off the 52-week high compared with 53.88% distance from its 52-week low. The 50-day simple moving average of the closing price is $2.80 and its 200-day simple moving average is $24.52. If we look at the stock’s price movements over the week, volatility stands at 9.61%, which increases to 12.27% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 59.34 to suggest the stock is neutral.
The consensus objective for the share price is $15.00, suggesting that the stock has a potential upside of 78.4% over the period.
The current price level is 11.36%, 15.73%, and -86.79% away from its SMA20, SMA50, and SMA200 respectively, with the SBFM price moving below the 50-day SMA on current market day. Sunshine Biopharma Inc (SBFM) stock is up 13.87% over the week and 32.20% over the past month. Its price is -99.43% year-to-date and -99.38% over the past year.
To reach the target analysts have set, the stock logically needs to grow 78.4 percent from here.
Outstanding shares total 2.00M with insiders holding 0.23% of the shares and institutional holders owning 1.84% of the company’s common stock. The company has a return on investment of -16.59% and return on equity of -17.98%. The forward price to earnings ratio is 4.38. The beta has a value of -0.94. Price to book ratio is 0.26 and price to sales ratio is 0.21.
